Anti-Helicobacter pylori agents. 5. 2-(Substituted guanidino)-4-arylthiazoles and aryloxazole analogues

Journal of Medicinal Chemistry

Volumn 45, Issue 1, 2002, Pages 143-150

  Katsura, Y ^a   Nishino, S ^a   Inoue, Y ^a   Sakane, K ^a   Matsumoto, Y ^a   Morinaga, C ^a   Ishikawa, H ^a   Takasugi, H ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [6 (ACETAMIDOMETHYL)PYRIDIN 2 YL] 2 [2 (2 METHOXYPHENYL)ETHYLGUANIDINO]THIAZOLE; AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH CITRATE; CIMETIDINE; CLARITHROMYCIN; GUANIDINE DERIVATIVE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; RANITIDINE; STOMACH SECRETION INHIBITOR; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SYNTHESIS; GUINEA PIG; HELICOBACTER PYLORI; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STOMACH SECRETION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; GASTRIC JUICE; GUANIDINES; GUINEA PIGS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; MALE; MICROBIAL SENSITIVITY TESTS; MYOCARDIUM; OXAZOLES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES; THIOPHENES;

EID: 0037011898     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010217j     Document Type: Article

References (29)

1. Drug therapy for Helicobacter pylori infection: Problems and pitfalls
2. Helicobacter pylori: Review of search findings
3. The treatment of Helicobacter pylori infection
4. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori
5. Ulcers as an infectious disease
6. The role of infectious agents in peptic ulcer disease
7. Helicobacter pylori and peptic ulcer disease
8. The role and treatment of Helicobacter pylori infection in peptic ulcer disease: A review of the relationship between Helicobacter pylori infection and peptic ulcer disease
9. The role of Helicobacter pylori in peptic ulcer disease
10. Helicobacter pylori
11. Therapy of Helicobacter pylori infections: Current status and future directions
12. Eradication of Helicobacter Pylori
13. Helicobacter Pylori and peptic ulcer disease
14. Treatment of Helicobacter pylori infection: A review of the world literature
15. Helicobacter pylori
16. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report
17. Helicobacter pylori and peptic ulcer disease: Evolution to revolution to resolution
18. Therapy and diagnostic tests used for Helicobacter pylori infection in the Scandinavian Countries in 1998
19. Anti-helicobacter pylori agents. 1. 2-alkylguanidino-4-furylthiazoles and related compounds
20. Anti-helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles
21. Anti-helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles
22. Anti-helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid Derivatives
23. Studies on antiulcer drugs. 7. 2-guanidino-4-pyridylthiazoles as histamine H2-receptor antagonists with potent gastroprotective effects against nonsteroidal antiinflammatory drug-induced injury
24. Studies on pyrimidine derivatives. XXXIII. Synthesis of alkyl pyrimidinyl ketones by means of nitrosation of alkyl pyrimidines
25. Studies on antiulcer drugs. VI. 4-furyl-2-guanidinothiazoles and related compounds as potent histamine H2-receptor antagonists
26. Some novel isoxazole photochemistry: A comparison with vinyl azide chemistry
27. Synthesis of 4(5)-Acyl-, 1-substituted 5-Acyl-, and 1-substituted 4-Acyl-1H-imidazoles from 4-aminoisoxazoles
28. The Japan Society of chemotherapy guidelines for MIC determination